These are targets to agree with a design partner, not achieved results.
Finance credibilityFinance accepts the reconciled baseline and every documented difference in scope or timing before options are evaluated.
Care credibilityCare and operations confirm all material blockers are visible; no hard gate is represented as permission to act.
Historical usefulnessReviewers identify which dated historical observation changed a question, assumption or option. Unexplained associations stay labelled unknown.
Decision speedMeasure the existing preparation process first, then test a provisional 50% reduction in time to a review-ready pack.
Decision usefulnessEach case includes alternatives, financial and human consequences, unresolved dependencies, an owner and review date, and an observable reversal trigger.
ReproducibilityAn independent reviewer reopens the saved record and reproduces material calculations from its version, inputs and evidence.
Commercial pullThe sponsor requests a further planning cycle and agrees a paid continuation against a named budget.
Reduced harm, improved clinical outcomes, realised savings and predictive accuracy require separate longitudinal evidence. Competitive advantage remains a hypothesis until buyers compare this workflow with their existing systems and alternatives.